Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Pagallo, U; O'Sullivan, S; Nevejans, N; Holzinger, A; Friebe, M; Jeanquartier, F; Jean-Quartier, C; Miernik, A.
The underuse of AI in the health sector: Opportunity costs, success stories, risks and recommendations
HEALTH TECHNOL-GER. 2023;
Doi: 10.1007/s12553-023-00806-7
Web of Science
FullText
FullText_MUG
- Leading authors Med Uni Graz
- Holzinger Andreas
- Co-authors Med Uni Graz
- Jean-Quartier Claire
- Jeanquartier Fleur
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- PurposeThis contribution explores the underuse of artificial intelligence (AI) in the health sector, what this means for practice, and how much the underuse can cost. Attention is drawn to the relevance of an issue that the European Parliament has outlined as a "major threat" in 2020. At its heart is the risk that research and development on trusted AI systems for medicine and digital health will pile up in lab centers without generating further practical relevance. Our analysis highlights why researchers, practitioners and especially policymakers, should pay attention to this phenomenon.MethodsThe paper examines the ways in which governments and public agencies are addressing the underuse of AI. As governments and international organizations often acknowledge the limitations of their own initiatives, the contribution explores the causes of the current issues and suggests ways to improve initiatives for digital health.ResultsRecommendations address the development of standards, models of regulatory governance, assessment of the opportunity costs of underuse of technology, and the urgency of the problem.ConclusionsThe exponential pace of AI advances and innovations makes the risks of underuse of AI increasingly threatening.
- Find related publications in this database (Keywords)
- AI in Medicine
- Underutilization of AI
- AI Policy
- Regulation of AI
- Ethics of AI
- AI Law